CMAC

CMAC is a world-class international hub for manufacturing research and training. Working in partnership with industry, its purpose is to transform current manufacturing processes into the medicine supply chain of the future.

Find out more

Our Vision



CMAC’s vision is to revolutionise the way pharmaceuticals and high value products are made.  The approaches developed and adopted within CMAC have been developed through close collaboration with industry and the support of its Tier 1 partners, which includes GlaxoSmithKline, AstraZeneca, Bayer, Lilly, Novartis, Pfizer, Roche and Takeda. Established in 2011, the CMAC has a £150m funding portfolio and currently comprises more than 130 staff and researchers, including academics, post docs, and more than 45 PhD students, as well as an experienced support team.

CMAC

  • conducts world class research in continuous manufacturing and advanced crystallisation;
  • conducts fundamental research;
  • develops new solutions to company specific problems;
  • delivers measurable successes that are of real benefit to society;
  • creates commercial opportunities for start-ups and major global companies;
  • produces a talent pipeline of highly skilled multi-disciplinary staff;
  • influences policy, government, and regulators;
  • understands and integrates with the broader supply chain context
  • collaborates with world class business and academia on an international basis.

Research

Industrially relevant research delivered by a multidisciplinary and collaborative academic team

Find out more
Award Winning Facility

Comprehensive suite of continuous processing, process analysis, and characterisation equipment housed in the Technology and Innovation Centre at Strathclyde

Find out more
Training & Skills

A vibrant world-class, multi-disciplinary PhD & MSc training programmes that will equip graduates with leading edge skills in pioneering continuous processes

Find out more
Translation to Industry

The demand-led manufacturing research scope of the Centre was co-created with our industry partners

Find out more

 

Our Partners



News

Strathclyde in Medicines Manufacturing Innovation Centre
The University of Strathclyde is a strategic partner in a new 56 million UK innovation centre, which will revolutionise the way medicines are manufactured..... more

Chemical Engineer Article May 2018
"Continuous crystallisation workflow enables high precision manufacturing of pharmaceuticals" Article by Amanda Doyle.... more

Chemistry World Article March 2018
"Solving the Crystal Maze" by Laura Fisher.... more